Tags

Type your tag names separated by a space and hit enter

Highly enantioselective mukaiyama aldol reaction of alpha,alpha-dichloro ketene silyl acetal: an efficient synthesis of a key intermediate for diltiazem.
J Org Chem. 2003 Feb 07; 68(3):974-9.JO

Abstract

An efficient synthesis of methyl (2R,3S)-3-(4-methoxyphenyl)glycidate (-)-2, a key intermediate for diltiazem (1), has been developed on the basis of the highly enantioselective Mukaiyama aldol reaction of p-anisaldehyde (4a) with alpha,alpha-dichloro ketene silyl acetal 5. Thus, the reaction using a stoichiometric amount of chiral oxazaborolidinone catalyst 12a proceeded to excellent yield (83%) and high enantioselectivity (96% ee), together with the chiral ligand 13a in nearly quantitative recovery. The reaction using a substoichiometric amount of 12e (20 mol %) also proceeded to excellent yield (88%), with somewhat lower enantioselectivity (77% ee). The aldol product 3a thus obtained was easily converted to (-)-2 in excellent yield (80%) and high optical purity (>99% ee). The highly enantioselective Mukaiyama aldol reaction with 5 catalyzed by 12a proved to be applicable to various aldehydes. An efficient preparation of 5 from inexpensive starting materials was also described.

Authors+Show Affiliations

CMC Research Laboratory, Tanabe Seiyaku Co., Ltd., 3-16-89 Kashima, Yodogawa-ku, Osaka 532-8505, Japan.No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

12558423

Citation

Imashiro, Ritsuo, and Tooru Kuroda. "Highly Enantioselective Mukaiyama Aldol Reaction of Alpha,alpha-dichloro Ketene Silyl Acetal: an Efficient Synthesis of a Key Intermediate for Diltiazem." The Journal of Organic Chemistry, vol. 68, no. 3, 2003, pp. 974-9.
Imashiro R, Kuroda T. Highly enantioselective mukaiyama aldol reaction of alpha,alpha-dichloro ketene silyl acetal: an efficient synthesis of a key intermediate for diltiazem. J Org Chem. 2003;68(3):974-9.
Imashiro, R., & Kuroda, T. (2003). Highly enantioselective mukaiyama aldol reaction of alpha,alpha-dichloro ketene silyl acetal: an efficient synthesis of a key intermediate for diltiazem. The Journal of Organic Chemistry, 68(3), 974-9.
Imashiro R, Kuroda T. Highly Enantioselective Mukaiyama Aldol Reaction of Alpha,alpha-dichloro Ketene Silyl Acetal: an Efficient Synthesis of a Key Intermediate for Diltiazem. J Org Chem. 2003 Feb 7;68(3):974-9. PubMed PMID: 12558423.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Highly enantioselective mukaiyama aldol reaction of alpha,alpha-dichloro ketene silyl acetal: an efficient synthesis of a key intermediate for diltiazem. AU - Imashiro,Ritsuo, AU - Kuroda,Tooru, PY - 2003/2/1/pubmed PY - 2003/8/13/medline PY - 2003/2/1/entrez SP - 974 EP - 9 JF - The Journal of organic chemistry JO - J Org Chem VL - 68 IS - 3 N2 - An efficient synthesis of methyl (2R,3S)-3-(4-methoxyphenyl)glycidate (-)-2, a key intermediate for diltiazem (1), has been developed on the basis of the highly enantioselective Mukaiyama aldol reaction of p-anisaldehyde (4a) with alpha,alpha-dichloro ketene silyl acetal 5. Thus, the reaction using a stoichiometric amount of chiral oxazaborolidinone catalyst 12a proceeded to excellent yield (83%) and high enantioselectivity (96% ee), together with the chiral ligand 13a in nearly quantitative recovery. The reaction using a substoichiometric amount of 12e (20 mol %) also proceeded to excellent yield (88%), with somewhat lower enantioselectivity (77% ee). The aldol product 3a thus obtained was easily converted to (-)-2 in excellent yield (80%) and high optical purity (>99% ee). The highly enantioselective Mukaiyama aldol reaction with 5 catalyzed by 12a proved to be applicable to various aldehydes. An efficient preparation of 5 from inexpensive starting materials was also described. SN - 0022-3263 UR - https://www.unboundmedicine.com/medline/citation/12558423/Highly_enantioselective_mukaiyama_aldol_reaction_of_alphaalpha_dichloro_ketene_silyl_acetal:_an_efficient_synthesis_of_a_key_intermediate_for_diltiazem_ DB - PRIME DP - Unbound Medicine ER -